|
1
|
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
|
Ann Neurol
|
2010
|
1.97
|
|
2
|
Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.
|
Am J Pathol
|
2010
|
1.58
|
|
3
|
TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function.
|
J Immunol
|
2011
|
1.47
|
|
4
|
Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A.
|
J Immunol
|
2002
|
1.04
|
|
5
|
Modulation of T cell activation by stomatin-like protein 2.
|
J Immunol
|
2008
|
0.91
|
|
6
|
Response of human oligodendrocyte progenitors to growth factors and axon signals.
|
J Neuropathol Exp Neurol
|
2010
|
0.90
|
|
7
|
Emerging multiple sclerosis disease-modifying therapies.
|
Curr Opin Neurol
|
2009
|
0.80
|
|
8
|
Neurite outgrowth is differentially impacted by distinct immune cell subsets.
|
Mol Cell Neurosci
|
2011
|
0.80
|